Evidence map›Paper›PMID 28795390›Full record

ArticleEuropean journal of drug metabolism and pharmacokinetics2018

Potential Influence of Endothelial Adsorption on the Delayed Time to Maximum Concentration of Biopharmaceuticals.

Joannes A A Reijers, Martijn J C Dane, Anton Jan van Zonneveld, Jacobus Burggraaf, Matthijs Moerland

Open access · hybridAbstract read
In one paragraph

Article in European journal of drug metabolism and pharmacokinetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Materials today. Bio · 2025
    Review
  4. Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette-dosed mice.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Fluctuations in Pharmacokinetics Profiles of Monoclonal Antibodies.European journal of drug metabolism and pharmacokinetics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joannes A A ReijersCentre for Human Drug Research (CHDR), Zernikedreef 8, 2333 CL, Leiden, The Netherlands. jreijers@chdr.nl.
Martijn J C DaneDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory of Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Anton Jan van ZonneveldDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory of Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Jacobus BurggraafCentre for Human Drug Research (CHDR), Zernikedreef 8, 2333 CL, Leiden, The Netherlands.
Matthijs MoerlandCentre for Human Drug Research (CHDR), Zernikedreef 8, 2333 CL, Leiden, The Netherlands.
Centre for Human Drug Research · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMaximum plasma concentration of biopharmaceuticals sometimes occurs long after completion of intravenous infusion. The objective of this research was to study the hypothetical adsorption of biopharmaceuticals to endothelium and infusion material, which may theoretically explain this phenomenon.

methodsInfusion procedures were mimicked in an artificial vessel covered with a confluent monolayer of endothelial cells. Three monoclonal antibodies (MAbs) and C1 inhibitor were studied.

resultsAdsorption of MAbs to endothelium was observed followed by release when the vessel was subsequently perfused with buffer. Adsorption to infusion material also occurred to various degrees and in a seemingly random fashion, with a loss of up to 15% during a single flush of the line, but release from the line was not seen.

conclusionsOur results indicate that adsorption of biopharmaceuticals to endothelium can occur. This observation can explain the increase in plasma concentration after completion of intravenous administration.

Indexed as

AdsorptionBiopharmaceuticsAntibodies, MonoclonalBevacizumabCells, CulturedComplement C1 Inhibitor ProteinEndotheliumHumansImmunoglobulin GInfusions, IntravenousTime FactorsTrastuzumabAntibodies, MonoclonalBevacizumabComplement C1 Inhibitor ProteinImmunoglobulin GTrastuzumab

Identifiers

PMID28795390
PMCPMC5794845
OpenAlexW2742575778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.